Wall Street is positive on Sutro Biopharma Inc (STRO). On average, analysts give STRO a Strong Buy rating. The average price target is $29.833, which means analysts expect the stock to rise by 516.38% over the next twelve months. That average ranking earns STRO an Analyst Rating of 72, which is better than 72% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating STRO a Strong Buy today. Find out what this means to you and get the rest of the rankings on STRO!